With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status ...

A new microfluidic device promises to revolutionize kidney disease screening by enabling rapid, accurate, and low-cost testing of creatinine levels in urine.

People with chronic kidney disease, or those at risk of heart failure, are greatly affected by potassium imbalances in the body. These can even be life-threatening. While wearable glucose monitors ...

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

A small study shows sensors embedded in a face mask appear to detect compounds linked to kidney disease. This is part of ...

The Kidney Stone Management Devices Market is expanding rapidly with rising demand for minimally invasive tools and tech-enabled outpatient care solutions. Valued at $2.62B in 2024 and set to hit ...

In November 2023, AWAK Technologies announced that its kidney disease progression prediction (KDPP) AI model for CKD patient care received breakthrough device designation by the FDA.

EndoTheia has completed the clinical trial of its FlexStone Basket, an independently steerable device, designed for kidney stone removal.

People with chronic kidney disease or those at risk of heart failure are greatly affected by potassium imbalances in the body. While wearable glucose monitors are now commonplace and have transformed ...